BLADDER CANCER
 
Worse perioperative outcomes seen in bladder Ca patients ≥80 years
A study investigating discharge destination and perioperative complications after radical cystectomy provides useful data for risk stratification and preoperative counseling of patients 80 years of age and older, said Hayden M. Hill, MD.
Get the data
ADVERTISEMENT
 
Pyruvate kinase appears to be bladder cancer marker
Pyruvate kinase, a primary driver of tumor glycolysis, is promising both as a biomarker of bladder cancer and as a drug target, researchers report.
Learn more
ADVERTISEMENT
Visit a Cysview® Reference Center in TX, OH, or CA
See hexaminolevulinate HCl in action in the operating room or clinic setting. Get answers and tips from an expert user. Travel and meal expenses are reimbursed. RSVP to discuss available dates and locations.

 
 
MORE FROM UROLOGY TIMES
 
Financial toxicity prevalent with bladder Ca patients
How has FDA label change affected treatment of advanced bladder Ca?
JOB OPPORTUNITIES